Pfizer and Sangamo initiate dosing in Phase III haemophilia A trial
Pfizer and genomic medicines company Sangamo Therapeutics have started dosing in the Phase III AFFINE...
Atossa Therapeutics reports positive safety data of Covid-19 drug
Atossa Therapeutics has reported positive interim safety data from the second cohort of participants in...
Opyl develops AI software to predict outcomes of Covid-19 trials
Australian company Opyl has developed new software that can forecast the outcomes of Covid-19 clinical...
Cynata begins enrolment in Covid-19 trial of Cymerus
Australia-based Cynata Therapeutics has started patient enrolment in the MEND clinical trial of Cymerus mesenchymal...
Novavax begins Phase II part of Covid-19 vaccine trial
Novavax has started enrolment for the Phase II part of an ongoing Phase I/II clinical...
Australia’s Queensland University begins Covid-19 vaccine trial
The University of Queensland in Australia has started dosing healthy adult participants in a Phase...
CSL Behring evaluates monoclonal antibody in Covid-19 patients
CSL Behring has started enrolment in a Phase II clinical trial of CSL312 for the...
First Covid-19 vaccine candidate trial begins in Australia
The first clinical trials of a Covid-19 vaccine developed in Australia have commenced at Royal...
Clover Biopharmaceuticals starts Phase I Covid-19 vaccine trial
China-based Clover Biopharmaceuticals has started dosing participants in a Phase I clinical trial of its...
Novavax begins Phase I/II trial of Covid-19 vaccine in Australia
US-based biotechnology firm Novavax has started enrolling participants in a Phase I/II clinical trial of...